Clinical trial in Australia tests effectiveness of naloxone by nose vs. injection for opioid overdose


What The Study Did:

A randomized clinical trial in Australia tested whether a dose of naloxone administered through the nose was as effective as the same dose delivered by injection to reverse opioid overdose as measured by the need for a rescue dose delivered by injection 10 minutes after the initial treatment. The study included 197 clients at a medically supervised injecting center in Sydney where eligible patients (18 or older with a history of injecting drug use) are allowed to inject drugs under the supervision of clinically trained staff who watch for signs of overdose.


To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/


Authors:

Paul Dietze, Ph.D., of the Burnet Institute in Melbourne, Australia, is the corresponding author.

(doi:10.1001/jamanetworkopen.2019.14977)


Editor’s Note:

The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###


Media advisory:

The full study is linked to this news release.


Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

http://jamanetwork.

com/

journals/

jamanetworkopen/

fullarticle/

10.

1001/

jamanetworkopen.

2019.

14977?utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_term=

111319


About JAMA Network Open:

JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. Every Wednesday and Friday, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

This part of information is sourced from https://www.eurekalert.org/pub_releases/2019-11/jn-cti111219.php

JAMA Network Media Relations

[email protected]
@JAMANetworkOpen

withyou android app

Leave a Reply

Your email address will not be published.